Descriptive and translational investigations into the human gut microbiome (GM) are rapidly
expanding; however, studies are largely restricted to industrialized populations in the USA …

The global spread of microbial resistance coupled with high costs and slow pace in the
discovery of a new antibiotic have made drug repositioning an attractive and promising …

Composition of the gut microbiota has been linked with human immunedeficiency virus (HIV)-
infected patients on antiretroviral therapy (ART). Evidence suggests that ART-treated …

Antiviral drugs are used globally as treatment and prophylaxis for long-term and acute viral
infections. Even though antivirals also have been shown to have off-target effects on …

There are still many unanswered questions regarding ARVs and the gut microbiome. It is,
therefore, critical for researchers to address the effect of distinct ARV drugs on the …

Background: We explored the long-term effects of cART on markers of gut damage,
microbial translocation, and paired gut/blood microbiota composition, with a focus on the …

Millions of individuals currently living with HIV globally are receiving antiretroviral therapy
(ART) that suppresses viral replication and improves host immune responses. The …

The roles of immunodeficiency and combined antiretroviral therapy (cART) in shaping the
gut microbiota in HIV-1-infected subjects (HISs) have not been described thoroughly by time …

Previous studies considering the role of the microbiome in people living with HIV largely
described viral acquisition as an intrusion on the host: microbiome interface. Re-framing this …

Introduction Antiretroviral therapy has improved life expectancy in HIV-infected patients.
However, people living with HIV under antiretroviral therapy are at higher risks of developing …